CLA 1200MG SOFTGEL
Natural health product licensed in Canada
- Other names
- NWN CLA 1200MG SOFTGEL
- Licence holder
- NEW WEST NUTRACEUTICALS INC
- NPN or DIN-HM
- 80088507
- Status
- Active licence
- Licence date
- 28 September 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide linoléique conjugué Source : Acide linoléique conjugué | 1,200 milligramme |
Non-medicinal ingredients
Eau purifiée, Glycérine, Caramel, Gélatine, d-alpha tocophérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity. May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80088507
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.